Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 209M 234M 194M 175M 328M 22.27B 334M 2.33B 922M 11.65B 878M 860M 36.88B P/E 2026 *
12.8x
P/E 2027 * 21.3x
Enterprise Value 294M 329M 272M 246M 461M 31.28B 468M 3.27B 1.29B 16.36B 1.23B 1.21B 51.8B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.73x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week-2.30%
1 month-2.30%
3 months-3.41%
6 months-4.49%
Current year-0.78%
1 week 2.5
Extreme 2.5
2.62
1 month 2.5
Extreme 2.5
2.73
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
4.04
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2005
Director of Finance/CFO - 19/12/2023
Chief Tech/Sci/R&D Officer - 31/12/2002
Director TitleAgeSince
Chairman - 30/12/2014
Director/Board Member 58 30/12/2014
Director/Board Member - 06/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/05/26 Buy 1,748 0.0021%
08/05/26 Buy 1,748 0.0021%
04/05/26 Buy 1,748 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-2.30%-14.14%+15.91% 237M
+0.45%+3.13%+54.96%+125.16% 1,135B
+0.94%+4.93%+39.86%+78.72% 635B
+0.39%+1.44%+25.77%+97.48% 505B
+1.43%+4.31%+46.20%+67.12% 378B
-3.21%-2.10%+60.72%+33.22% 358B
-0.41%+2.64%+22.48%+49.82% 295B
+0.23%+3.66%+2.57%+23.69% 266B
+1.22%+4.63%+52.40%+64.85% 237B
+1.70%+3.67%+31.21%+102.15% 193B
Average +0.13%+2.28%+32.20%+65.81% 400.39B
Weighted average by Cap. +0.42%+2.85%+41.40%+83.60%

Financials

2026 *2027 *
Net sales 365M 408M 338M 306M 572M 38.82B 581M 4.06B 1.61B 20.31B 1.53B 1.5B 64.3B 392M 438M 363M 328M 614M 41.7B 624M 4.36B 1.73B 21.81B 1.64B 1.61B 69.05B
Net income 16.7M 18.68M 15.45M 13.99M 26.18M 1.78B 26.61M 186M 73.54M 929M 70.09M 68.6M 2.94B 9.5M 10.62M 8.79M 7.96M 14.89M 1.01B 15.14M 106M 41.84M 529M 39.87M 39.02M 1.67B
Net Debt 84.7M 94.72M 78.36M 70.95M 133M 9.01B 135M 943M 373M 4.71B 356M 348M 14.92B 78.7M 88.01M 72.81M 65.93M 123M 8.37B 125M 876M 347M 4.38B 330M 323M 13.87B
Projected Income Statement - Annual - Laboratorio Reig Jofre, S.A.
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,512
Date Price Change Volume
26/10/26 €2.550 -1.16% 37,850
23/10/26 €2.580 0.00% 3,275
22/10/26 €2.580 -0.77% 4,786
21/10/26 €2.600 0.00% 6,053
20/10/26 €2.600 -0.38% 5,177
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Laboratorio Reig Jofre, S.A.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Laboratorio Reig Jofre, S.A.